Healthcare Triangle, Inc. is facing potential delisting from the Nasdaq Stock Market after failing to meet the minimum bid price requirement. The company filed a Form 8-K with the Securities and Exchange Commission (SEC) on October 2, 2026, detailing the situation.
The filing, accessible under accession number 0001213900-26-106533, indicates that Healthcare Triangle received a notice from the Nasdaq Listing Qualifications Department on October 1, 2026. The notice states that the company is not in compliance with Nasdaq Listing Rule 5550(a)(2), which mandates that the closing bid price of a company's common stock be at least $1.00 per share for continued listing.
Background on Healthcare Triangle
Healthcare Triangle, Inc. is a company that specializes in computer integrated systems design, primarily serving the healthcare industry. The firm is incorporated in Delaware and has its headquarters in Pleasanton, California. The company trades under the symbol "HCTI" on the Nasdaq Stock Market.
Form 8-K is a current report that companies use to disclose major events that shareholders should know about. This form is often used to report significant events such as changes in control, bankruptcy, or compliance issues.
Details from the Filing
The filing reveals that Healthcare Triangle has faced challenges in maintaining its stock price. Specifically, it states:
"On October 1, 2026, Healthcare Triangle, Inc. received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC notifying the Company that it is not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2)."
Due to previous reverse stock splits, the company is not eligible for the standard 180-day compliance period typically granted to companies in this situation. The filing notes:
"The Company is not eligible for any compliance period because it has effected reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one."
As a result, the Nasdaq Listing Qualifications Department issued a Staff Delisting Determination letter, which states that unless the company appeals by October 8, 2026, trading of its securities will be suspended on October 12, 2026.
Impact of the Filing
This situation may affect various stakeholders, including shareholders, employees, and potential investors. Shareholders may be concerned about the value of their investments, while employees may worry about job security. Potential investors might view the delisting as a risk factor, which could deter them from investing in the company.
What's Next
Healthcare Triangle intends to request a hearing before a Nasdaq Hearings Panel, which will stay the suspension of its securities pending the Panel's decision. The company plans to present a plan to regain compliance with the Bid Price Rule, which may include further reverse stock splits if necessary. However, there is no guarantee that the Panel will grant the request for continued listing or that the company will be able to meet compliance within any additional time granted.
The filing does not say what happens next beyond the appeal process.